NIKI · Niki BioSolutions, Inc. · Documents
Market Cap
$6.49M
Shares
3.12M
Volume · Oct 20
22.57K
Avg daily vol (3M)
144.54K
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| 6-K | — | 2023-11-30 | — | |
| 6-K/A | — | 2023-11-21 | — | |
| 6-K | — | 2023-11-16 | — | |
| 6-K | — | 2023-09-11 | — | |
| 6-K | — | 2023-08-10 | — | |
| 6-K/A | — | 2023-07-14 | — | |
| 6-K | — | 2023-06-30 | — | |
| 6-K | — | 2023-06-30 | — | |
| 6-K | — | 2023-06-09 | — | |
| 6-K | — | 2023-05-08 | — | |
| 6-K | — | 2023-05-05 | — | |
| 6-K | — | 2023-05-01 | — | |
| 20-F | — | 2023-04-28 | 2022-12-31 | |
| 6-K | — | 2023-04-28 | — | |
| 6-K | — | 2023-03-27 | — | |
| 6-K/A | — | 2023-03-02 | — | |
| 6-K | — | 2023-02-22 | — | |
| 6-K | — | 2023-02-10 | — | |
| 6-K | — | 2023-02-06 | — | |
| 6-K | — | 2023-01-25 | 2023-01-24 | |
| 6-K | — | 2023-01-20 | — | |
| 20-F/A | — | 2023-01-17 | 2021-12-31 | |
| 6-K | — | 2022-12-22 | — | |
| F-3 | — | 2022-12-19 | — | |
| 6-K | — | 2022-12-16 | — | |
| 6-K | — | 2022-12-09 | — | |
| 6-K | — | 2022-11-18 | — | |
| 6-K | — | 2022-11-08 | — | |
| 6-K | — | 2022-09-30 | 2022-06-30 | |
| 6-K | — | 2022-09-15 | — | |
| 6-K | — | 2022-07-11 | — | |
| 6-K | — | 2022-06-09 | — | |
| 6-K | — | 2022-05-31 | — | |
| 20-F | — | 2022-04-29 | 2021-12-31 | |
| 6-K | — | 2022-04-29 | 2021-04-29 | |
| 6-K | — | 2022-01-10 | — | |
| 6-K | — | 2021-12-03 | — | |
| 6-K | — | 2021-11-17 | — | |
| 6-K | — | 2021-10-19 | — | |
| 6-K | — | 2021-09-15 | 2021-06-30 | |
| 6-K | — | 2021-08-27 | — | |
| 6-K | — | 2021-05-26 | — | |
| 20-F | — | 2021-04-19 | 2020-12-31 | |
| 6-K | — | 2021-04-19 | — | |
| 6-K | — | 2021-03-26 | — | |
| 6-K | — | 2021-01-25 | — | |
| 6-K | — | 2021-01-22 | — | |
| 6-K | — | 2021-01-20 | — | |
| 6-K | — | 2020-12-10 | — | |
| 6-K | — | 2020-10-20 | — |
Showing 51–100 of 122 filings